A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR Study-Reference-Cited by-同舟云学术

A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR Study

Published:2020-07-27 Issue:10 Volume:16 Page:1412-1425
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Boada Mercè¹²,López Oscar L.³,Olazarán Javier⁴⁵,Núñez Laura⁶,Pfeffer Michael⁷,Paricio María⁸,Lorites Jesús⁹,Piñol‐Ripoll Gerard¹⁰,Gámez José E.¹¹,Anaya Fernando¹²,Kiprov Dobri¹³,Lima José¹⁴,Grifols Carlota⁶,Torres Mireia⁶,Costa Montserrat⁶,Bozzo Jordi⁶,Szczepiorkowski Zbigniew M.¹⁵,Hendrix Suzanne¹⁶,Páez Antonio⁶

Affiliation:

1. Research Center and Memory Clinic Fundació ACE Institut Català de Neurociències Aplicades ‐ Universitat Internacional de Catalunya Barcelona Spain

2. Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED) Instituto de Salud Carlos III Madrid Spain

3. Departments of Neurology and Psychiatry University of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA

4. Neurology Service Hospital General Universitario Gregorio Marañón Madrid Spain

5. Memory Disorders Unit – HM Hospitals Madrid Spain

6. Alzheimer's Research Group Grifols Barcelona Spain

7. Medical Services Allied Biomedical Research Institute, Inc. Miami Florida USA

8. Center for Prevention of Alzheimer´s Disease Miami Dade Medical Research Institute Miami Florida USA

9. Medical Services L&L Research Choices, Inc. Miami Florida USA

10. Seizure Disorders Unit Clinical Neuroscience Research IRBLleida‐Hospital Universitari Santa Maria Lleida Spain

11. Psychiatry Department Galiz Research Hialeah Florida USA

12. Nephrology Service Hospital General Universitario Gregorio Marañón Madrid Spain

13. Apheresis Care Group and Fresenius Medical Care San Francisco California USA

14. American Red Cross Southern Blood Services Region Atlanta Georgia USA

15. Department of Pathology and Laboratory Medicine Dartmouth Hitchcock Medical Center Lebanon New Hampshire USA

16. Pentara Corporation Salt Lake City Utah USA

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12137

Reference57 articles.

1. National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach

2. AD lesions and infarcts in demented and non-demented Japanese-American men

3. Concurrence of TDP-43, tau and α-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies

4. The Early Involvement of the Innate Immunity in the Pathogenesis of Lateonset Alzheimers Disease: Neuropathological, Epidemiological and Genetic Evidence

5. Memantine Treatment in Patients With Moderate to Severe Alzheimer Disease Already Receiving Donepezil

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The therapeutic effects of blood plasma transfusions in neurodegenerative conditions: a scoping review protocol (Preprint);2024-09-01

2. Protective role of serum albumin in dementia: a prospective study from United Kingdom biobank;Frontiers in Neurology;2024-08-14

3. Molecular dynamics of amyloid-β transport in Alzheimer's disease: Exploring therapeutic plasma exchange with albumin replacement – Current insights and future perspectives;Neurología;2024-08

4. Low-Density Lipoprotein Receptor-Related Protein 1 as a Potential Therapeutic Target in Alzheimer’s Disease;Pharmaceutics;2024-07-17

5. Engineered Antibodies to Improve Efficacy against Neurodegenerative Disorders;International Journal of Molecular Sciences;2024-06-18